10 - 11 a.m. | WashU Medical Spotlight with Beau Ances, MD, PhD, the Daniel J. Brennan, MD, Professor of Neurology: Forerunners of Forgetfulness: The Role of Neuroimaging in Alzheimer's Disease
Cullenbine Classroom, Anheuser-Busch Hall
Alzheimer's disease is the sixth leading cause of death in the United States with millions of Americans projected to develop memory problems in the upcoming decades. Alzheimer’s disease results from the deposition of proteins, including amyloid-beta and tau, in the brain. Groundbreaking neuroimaging research performed at Washington University School of Medicine has shown that changes in amyloid-beta and tau occur more than 15 years prior to the onset of clinical symptoms. This presentation will focus on new biomarkers that can map the progression of Alzheimer's disease. This talk, given by Beau Ances, the Daniel J. Brennan, MD, Professor of Neurology, will also discuss how neuroimaging is being used as a clinical endpoint for evaluating potential therapies.